Location History:
- Lexington, MA (US) (1998 - 2013)
- Westport, CT (US) (2017)
Company Filing History:
14 out of 2,968 
5 out of 27 
1 out of 1 Years Active: 1998-2017
Title: The Innovation Journey of Andrew P McMahon in Lexington, MA
Introduction: Andrew P McMahon, a prominent inventor based in Lexington, MA, has made significant contributions to the fields of finance, medical decision-making, and cellular signaling pathways. With a remarkable portfolio of 23 patents, McMahon's work has revolutionized how data from different industries can be harnessed for financial and medical insights.
Latest Patents: Among McMahon's latest patents is a groundbreaking method and system for generating and aggregating models based on disparate data from insurance, financial services, and public industries. This innovative approach allows for the training of models using classification training with data from various sources, leading to more informed financial and medical decisions. Another notable patent is the system for screening agonists/antagonists of cellular signaling pathways, which enables the observation of cell membrane-associated protein response to drugs in living cells.
Career Highlights: McMahon has worked with prestigious organizations such as the President and Fellows of Harvard College, where he honed his expertise in innovation and technology. His passion for pushing boundaries and seeking novel solutions has led to the development of cutting-edge inventions that have the potential to transform industries.
Collaborations: Throughout his career, McMahon has collaborated with exceptional professionals in the field, including Philip W Ingham and Clifford J Tabin. These collaborations have not only enhanced the quality of his work but have also fostered a culture of innovation and knowledge exchange.
Conclusion: Andrew P McMahon's journey as an inventor in Lexington, MA, exemplifies a relentless pursuit of innovation and a commitment to pushing the boundaries of what is possible. With a diverse portfolio of patents and a track record of collaboration with esteemed colleagues, McMahon continues to leave a lasting impact on the fields of finance, medical decision-making, and cellular signaling pathways.